FLPIM
CRDF icon

F.L. Putnam Investment Management’s Cardiff Oncology CRDF Stock Holding History

F.L. Putnam Investment Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$964K Sell
595,127
-201
-0% -$413 0.01% 328
2025
Q4 		$1.67M Sell
595,328
-1,905
-0.3% -$4.42K 0.02% 272
2025
Q3 		$1.23M Buy
597,233
+543,370
+1,009% +$1.5M 0.02% 312
2025
Q2 		$170K Buy
+53,863
New +$164K ﹤0.01% 568

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

F.L. Putnam Investment Management's CRDF Position: Q1 2026 in Review

F.L. Putnam Investment Management reduced its Cardiff Oncology (CRDF) stake by 0.03% in Q1 2026, selling an estimated $413 and leaving 595,127 shares worth $964K. The position accounts for 0.01% of the portfolio, ranked #328.

F.L. Putnam Investment Management first reported a position in CRDF in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.67M in Q4 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • F.L. Putnam Investment Management held 595,127 shares of Cardiff Oncology worth $964K as of Q1 2026.
  • F.L. Putnam Investment Management sold 201 Cardiff Oncology shares in Q1 2026, an estimated $413.
  • Cardiff Oncology made up 0.01% of F.L. Putnam Investment Management's portfolio in Q1 2026, its #328 holding.
  • F.L. Putnam Investment Management first reported a position in Cardiff Oncology in Q2 2025 and has held it in 4 quarters since.
  • F.L. Putnam Investment Management's Cardiff Oncology position peaked at $1.67M in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q1 2026, filed 5 May 2026.